Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma

Clinical trial NCT03027388 · COMPLETED

Trial details

NCT number: NCT03027388
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Astrocytoma, Grades II, III and IV Glioblastoma Multiforme Giant Cell Glioblastoma Glioma Oligodendrogliomas

Start date: 2019-01-09
Primary completion: 2022-08-15
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.